CRISPR genome editing treatment still effective after one year
The first team to use CRISPR to edit a disease-causing gene in humans has found the effects are persistent up to a year later...
Dr James Moore was a Volunteer Writer at BioNews. James is currently working as a technical writer at at Genedata in Basel, Switzerland. He has completed studying for a PhD at the University of Zurich, where his research focused on how protein translation errors impact health and ageing. Previously, he obtained an MSci in Genetics at University College London, where he was interested in medical genetics and evolutionary processes. James is passionate about communicating science with non-scientists, and enjoys travelling and sports.
The first team to use CRISPR to edit a disease-causing gene in humans has found the effects are persistent up to a year later...
Differences in the expression of DNA repair genes due to environmental impacts may help explain why breast cancer mortality is higher in black women than white women, researchers report...
The UK government has investigated possible future applications of genomics beyond healthcare and the potential risks involved in its growing use, published in an open report...
Researchers have identified a molecule that could be used as a drug to prevent metastasis, a process by which cancer can spread and cause death...
Same-sex couples in Switzerland will be able to marry from July 2022 and will have the same access to assisted reproduction as heterosexual couples...
Analysis of DNA sequences from over 450,000 participants in the UK BioBank has helped connect hundreds of genes to health outcomes...
Gene therapy given to children born with a deadly immune disease remains safe and effective ten years on, researchers report...
BioNews, published by the Progress Educational Trust (PET), provides news and comment on genetics, assisted conception, embryo/stem cell research and related areas.